BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 7031980)

  • 1. The in vitro inhibitory effect on thrombin by 2,3-diphosphoglycerate.
    Del Principe D; Strappini PM; Del Vecchio S; Menichelli A; Biancini G; Cosmi EV; Bastianon V; D'Arcangelo C
    Thromb Haemost; 1981 Oct; 46(3):581-3. PubMed ID: 7031980
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Homophenotypic Aalpha R16H fibrinogen (Kingsport): uniquely altered polymerization associated with slower fibrinopeptide A than fibrinopeptide B release.
    Galanakis DK; Neerman-Arbez M; Scheiner T; Henschen A; Hubbs D; Nagaswami C; Weisel JW
    Blood Coagul Fibrinolysis; 2007 Dec; 18(8):731-7. PubMed ID: 17982313
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The kinetics of inhibition of the action of thrombin by the fibrinopeptides formed during the clotting of fibrinogen.
    Silver A; Murray M
    Thromb Diath Haemorrh; 1966 Jul; 16(1):277-95. PubMed ID: 6011260
    [No Abstract]   [Full Text] [Related]  

  • 4. Fibrinogen Matsumoto V: a variant with Aalpha19 Arg-->Gly (AGG-->GGG). Comparison between fibrin polymerization stimulated by thrombin or reptilase and fibrin monomer polymerization.
    Tanaka H; Terasawa F; Ito T; Tokunaga S; Ishida F; Kitano K; Kiyosawa K; Okumura N
    Thromb Haemost; 2001 Jan; 85(1):108-13. PubMed ID: 11204560
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional evaluation of an inherited abnormal fibrinogen: fibrinogen "Baltimore".
    Beck EA; Shainoff JR; Vogel A; Jackson DP
    J Clin Invest; 1971 Sep; 50(9):1874-84. PubMed ID: 5564395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Release of fibrinopeptides by the slow and fast forms of thrombin.
    Vindigni A; Di Cera E
    Biochemistry; 1996 Apr; 35(14):4417-26. PubMed ID: 8605191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of the esterase (TAMe) and clotting activities of human and bovine thrombin preparations.
    Lanchantin GF; Presant CA; Hart DW; Friedmann JA
    Thromb Diath Haemorrh; 1965 Sep; 14(1-2):159-75. PubMed ID: 16955973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acids and peptides. XVI. Synthesis of N-terminal tetrapeptide analogs of fibrin alpha-chain and their inhibitory effects on fibrinogen/thrombin clotting.
    Kawasaki K; Hirase K; Miyano M; Tsuji T; Iwamoto M
    Chem Pharm Bull (Tokyo); 1992 Dec; 40(12):3253-60. PubMed ID: 1294328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prothrombin fragment 1 + 2, thrombin-antithrombin III-complexes and fibrinopeptide A in spontaneously clotting whole blood in vitro. Effects of heparin addition and antithrombin III deficiency.
    Herren T; Straub PW; Haeberli A
    Thromb Haemost; 1994 Jan; 71(1):49-53. PubMed ID: 8165646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies of an inhibitor of the thrombin-fibrinogen reaction localized in rat liver microsomes. Interference with the polymerization step.
    Helgeland L
    Thromb Haemost; 1976 Dec; 36(3):509-16. PubMed ID: 1037148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
    Okumura N; Haneishi A; Terasawa F
    Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of tyrosine for phenylalanine in fibrinopeptide A results in preferential thrombin cleavage of fibrinopeptide B from fibrinogen.
    Rooney MM; Mullin JL; Lord ST
    Biochemistry; 1998 Sep; 37(39):13704-9. PubMed ID: 9753458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Blood coagulation and acute iron toxicity. Reversible iron-induced inactivation of serine proteases in vitro.
    Rosenmund A; Haeberli A; Straub PW
    J Lab Clin Med; 1984 Apr; 103(4):524-33. PubMed ID: 6421970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of a coagulant thrombin-like enzyme from the venom of Bothrops leucurus.
    Magalhães A; Magalhães HP; Richardson M; Gontijo S; Ferreira RN; Almeida AP; Sanchez EF
    Comp Biochem Physiol A Mol Integr Physiol; 2007 Apr; 146(4):565-75. PubMed ID: 16481207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Review of some unusual effects of calcium binding to fibrinogen.
    Mihalyi E
    Biophys Chem; 2004 Dec; 112(2-3):131-40. PubMed ID: 15572240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in pH associated with clotting of fibrinogen. Kinetic studies of the pH shift and correlation of the pH change with the release of fibrinopeptides and the ensuing polymerization.
    Mihalyi E; Tercero JC; Diaz-Mauriño T
    Biochemistry; 1991 May; 30(19):4753-62. PubMed ID: 2029517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intracranial hemorrhage and hemostasis. Monitoring patients after intracranial hemorrhage by determination and follow-up of activation products of blood coagulation].
    Menges T; von Lessen A; Welters I; Wagner RM; Ruwoldt R; Boldt J; Hempelmann G
    Infusionsther Transfusionsmed; 1994 Aug; 21(4):244-50. PubMed ID: 7950289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DIFFERENCES IN THE CLOTTING OF LAMPREY FIBRINOGEN BY LAMPREY AND BOVINE THROMBINS.
    DOOLITTLE RF
    Biochem J; 1965 Mar; 94(3):735-41. PubMed ID: 14340065
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Haemoglobin inhibition of fibrin polymerization and clotting.
    Brezniak DV; Moon DG; Beaver JA; Fenton JW
    Blood Coagul Fibrinolysis; 1994 Feb; 5(1):139-43. PubMed ID: 8180334
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis for measurement of circulating fibrinogen derivatives.
    Wilner GD
    Prog Hemost Thromb; 1978; 4():211-48. PubMed ID: 152445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.